187 related articles for article (PubMed ID: 37781737)
21. Exosomes from high glucose-treated glomerular endothelial cells trigger the epithelial-mesenchymal transition and dysfunction of podocytes.
Wu X; Gao Y; Xu L; Dang W; Yan H; Zou D; Zhu Z; Luo L; Tian N; Wang X; Tong Y; Han Z
Sci Rep; 2017 Aug; 7(1):9371. PubMed ID: 28839221
[TBL] [Abstract][Full Text] [Related]
22. The crosstalk between glomerular endothelial cells and podocytes controls their responses to metabolic stimuli in diabetic nephropathy.
Albrecht M; Sticht C; Wagner T; Hettler SA; De La Torre C; Qiu J; Gretz N; Albrecht T; Yard B; Sleeman JP; Garvalov BK
Sci Rep; 2023 Oct; 13(1):17985. PubMed ID: 37863933
[TBL] [Abstract][Full Text] [Related]
23. miR302a-3p May Modulate Renal Epithelial-Mesenchymal Transition in Diabetic Kidney Disease by Targeting ZEB1.
Tang WB; Zheng L; Yan R; Yang J; Ning J; Peng L; Zhou Q; Chen L
Nephron; 2018; 138(3):231-242. PubMed ID: 29227974
[TBL] [Abstract][Full Text] [Related]
24. Endothelial PFKFB3 plays a critical role in angiogenesis.
Xu Y; An X; Guo X; Habtetsion TG; Wang Y; Xu X; Kandala S; Li Q; Li H; Zhang C; Caldwell RB; Fulton DJ; Su Y; Hoda MN; Zhou G; Wu C; Huo Y
Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1231-9. PubMed ID: 24700124
[TBL] [Abstract][Full Text] [Related]
25. IGFBP5 promotes diabetic kidney disease progression by enhancing PFKFB3-mediated endothelial glycolysis.
Song C; Wang S; Fu Z; Chi K; Geng X; Liu C; Cai G; Chen X; Wu D; Hong Q
Cell Death Dis; 2022 Apr; 13(4):340. PubMed ID: 35418167
[TBL] [Abstract][Full Text] [Related]
26. Changes of podocyte p130Cas in diabetic conditions.
Ha TS; Choi JY; Park HY; Han GD
J Nephrol; 2013; 26(5):870-6. PubMed ID: 23559070
[TBL] [Abstract][Full Text] [Related]
27. Tectorigenin attenuates diabetic nephropathy by improving vascular endothelium dysfunction through activating AdipoR1/2 pathway.
Yang S; Ma C; Wu H; Zhang H; Yuan F; Yang G; Yang Q; Jia L; Liang Z; Kang L
Pharmacol Res; 2020 Mar; 153():104678. PubMed ID: 32014572
[TBL] [Abstract][Full Text] [Related]
28. PFKFB3 Inhibits Fructose Metabolism in Pulmonary Microvascular Endothelial Cells.
Lee JY; Stevens RP; Pastukh VV; Pastukh VM; Kozhukhar N; Alexeyev MF; Reisz JA; Nerguizian D; D'Alessandro A; Koloteva A; Gwin MS; Roberts JT; Borchert GM; Wagener BM; Pittet JF; Graham BB; Stenmark KR; Stevens T
Am J Respir Cell Mol Biol; 2023 Sep; 69(3):340-354. PubMed ID: 37201952
[TBL] [Abstract][Full Text] [Related]
29. ELABELA/APJ Axis Prevents Diabetic Glomerular Endothelial Injury by Regulating AMPK/NLRP3 Pathway.
Chen Z; Wang Z; Hu Y; Lin H; Yin L; Kong J; Zhang Y; Hu B; Li T; Zheng X; Yang Q; Ye S; Wang S; Zhou Q; Zheng C
Inflammation; 2023 Dec; 46(6):2343-2358. PubMed ID: 37540330
[TBL] [Abstract][Full Text] [Related]
30. Renal endothelial protein C receptor expression and shedding during diabetic nephropathy.
Lattenist L; Ochodnický P; Ahdi M; Claessen N; Leemans JC; Satchell SC; Florquin S; Gerdes VE; Roelofs JJ
J Thromb Haemost; 2016 Jun; 14(6):1171-82. PubMed ID: 26990852
[TBL] [Abstract][Full Text] [Related]
31. Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis.
Liu XT; Huang Y; Liu D; Jiang YC; Zhao M; Chung LH; Han XD; Zhao Y; Chen J; Coleman P; Ting KK; Tran C; Su Y; Dennis CV; Bhatnagar A; Liu K; Don AS; Vadas MA; Gorrell MD; Zhang S; Murray M; Kavurma MM; McCaughan GW; Gamble JR; Qi Y
J Transl Med; 2024 Jan; 22(1):43. PubMed ID: 38200582
[TBL] [Abstract][Full Text] [Related]
32. The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.
Kim Y; Lim JH; Kim MY; Kim EN; Yoon HE; Shin SJ; Choi BS; Kim YS; Chang YS; Park CW
J Am Soc Nephrol; 2018 Apr; 29(4):1108-1127. PubMed ID: 29330340
[TBL] [Abstract][Full Text] [Related]
33. Silencing long noncoding RNA-CES1P1 suppresses glomerular endothelial cell inflammation in diabetic nephropathy.
Zhang X; Ren L; Wei J; Ni Y; Sun L; Zhao X; Zhang Y; Qiao H
Int Immunopharmacol; 2022 Sep; 110():108820. PubMed ID: 35834955
[TBL] [Abstract][Full Text] [Related]
34. GPR56 Promotes Diabetic Kidney Disease Through eNOS Regulation in Glomerular Endothelial Cells.
Wu J; Wang Z; Cai M; Wang X; Lo B; Li Q; He JC; Lee K; Fu J
Diabetes; 2023 Nov; 72(11):1652-1663. PubMed ID: 37579299
[TBL] [Abstract][Full Text] [Related]
35. LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-
Hong Q; Zhang L; Fu J; Verghese DA; Chauhan K; Nadkarni GN; Li Z; Ju W; Kretzler M; Cai GY; Chen XM; D'Agati VD; Coca SG; Schlondorff D; He JC; Lee K
J Am Soc Nephrol; 2019 Apr; 30(4):546-562. PubMed ID: 30858225
[TBL] [Abstract][Full Text] [Related]
36. Ipragliflozin Ameliorates Diabetic Nephropathy Associated with Perirenal Adipose Expansion in Mice.
Okuma H; Mori K; Nakamura S; Sekine T; Ogawa Y; Tsuchiya K
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298949
[TBL] [Abstract][Full Text] [Related]
37. Glycolytic and gluconeogenic states in an enzyme system reconstituted from phosphofructokinase and fructose 1,6-bisphosphatase.
Schellenberger W; Eschrich K; Hofmann E
Biomed Biochim Acta; 1985; 44(4):503-16. PubMed ID: 2992456
[TBL] [Abstract][Full Text] [Related]
38. AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose.
Huang K; Huang J; Chen C; Hao J; Wang S; Huang J; Liu P; Huang H
Cell Signal; 2014 Mar; 26(3):629-38. PubMed ID: 24342046
[TBL] [Abstract][Full Text] [Related]
39. Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy.
Nasu T; Maeshima Y; Kinomura M; Hirokoshi-Kawahara K; Tanabe K; Sugiyama H; Sonoda H; Sato Y; Makino H
Diabetes; 2009 Oct; 58(10):2365-75. PubMed ID: 19587360
[TBL] [Abstract][Full Text] [Related]
40. Promoting effects of the adipokine, apelin, on diabetic nephropathy.
Zhang BH; Wang W; Wang H; Yin J; Zeng XJ
PLoS One; 2013; 8(4):e60457. PubMed ID: 23577111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
